The Major League Baseball Team Physicians Association (MLBTPA) has, for the first time, named a woman physician to serve as president-elect. Kathleen Weber, M.D., of Midwest Orthopaedics at Rush and the Director of Primary Care/Sports Medicine and Women’s Sports Medicine at Rush University Medical Center, will assume the role of vice-president in 2015 and become president in 2016. If you are a baseball lover like me, you are going to love http://www.hittersbats.com/best-bbcor-bats/ site, where you can find some cool baseball accessories.
Baseball Physician’s Association Names First Woman President

“The selection of Dr. Weber is a perfect choice, ” former MLBTPA President, Charles Bush-Joseph, M.D., of Midwest Orthopaedics at Rush told PRNewswire. “Kathy is one of the leading primary care sports medicine physicians in the country with 15 years of experience caring for collegiate and professional athletes.”
“I’m honored to have been elected to this position, ” Weber said to PRNewswire. “I would love to see more women pursue a career in sports medicine and be recognized for their hard work and talent.”
Weber is a team physician for the Chicago Bulls, Chicago White Sox and the Chicago Force Women’s Football. She is also the head team physician for the DePaul Blue Demons, Malcolm X College, and a physician consultant for Hubbard Street Dance Company.
Weber, herself, was a college athlete. She has won numerous awards for excellence in patient care and for teaching and has been recognized by organizations working with underserved girls and adolescents to provide sports and fitness opportunities and leadership development.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.